Beltran, P. J., Calzone, F. J., Mitchell, P., Chung, Y., Cajulis, E., Moody, G., . . . Konecny, G. E. (2014). Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy.
शिकागो स्टाइल उद्धरणBeltran, Pedro J., et al. Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy. 2014.
एमएलए उद्धरणBeltran, Pedro J., et al. Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy. 2014.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.